Hepatic and splanchnic oxygen consumption during acute hypoxemic hypoxia in anesthetized pigs

Evaluating the Risks of High Altitude Travel in Chronic Liver Disease Patients

Luks, Andrew M., and Erik R. Swenson. Clinician's Corner: Evaluating the risks of high altitude travel in chronic liver disease patients. High Alt Med Biol 16:80-88, 2015.--With improvements in the quality of health care, people with chronic medical conditions are experiencing better quality of life and increasingly participating in a wider array of activities, including travel to high altitude. Whenever people with chronic diseases travel to this environment, it is important to consider whether the physiologic responses to hypobaric hypoxia will interact with the underlying medical condition such that the risk of acute altitude illness is increased or the medical condition itself may worsen. This review considers these questions as they pertain to patients with chronic liver disease. While the limited available evidence suggests there is no evidence of liver injury or dysfunction in normal individuals traveling as high as 5000 m, there is reason to suspect that two groups of cirrhosis patients are at increased risk for problems, hepatopulmonary syndrome patients, who are at risk for severe hypoxemia following ascent, and portopulmonary hypertension patients who may be at risk for high altitude pulmonary edema and acute right ventricular dysfunction. While liver transplant patients may tolerate high altitude exposure without difficulty, no information is available regarding the risks of long-term residence at altitude with chronic liver disease. All travelers with cirrhosis require careful pre-travel evaluation to identify conditions that might predispose to problems at altitude and develop risk mitigation strategies for these issues. Patients also require detailed counseling about recognition, prevention, and treatment of acute altitude illness and may require different medication regimens to prevent or treat altitude illness than used in healthy individuals.

THE HEPATOSPLANCHNIC CONTRIBUTION TO HYPERLACTATEMIA IN ENDOTOXIC SHOCK: EFFECTS OF TISSUE ISCHEMIA

We investigated the role of the hepatosplanchnic region in the hyperlactatemia observed during endotoxic shock. The study included 18 dogs anesthetized with pentobarbital and mechanically ventilated. After baseline measurements, including gut lactate production (GLP), liver lactate uptake (LLU), liver lactate extraction (LLE), and hepatosplanchnic lactate production (HSLP), each dog received 2 mg/kg of E. coli endotoxin. After a second set of measurements, cardiac tamponade was induced in 12 dogs (EDTX + Tamp) by repeated injections of normal saline into the pericardial sac to progressively reduce cardiac output and hepatic blood flow. The six remaining dogs served as septic controls (EDTX). From a net lactate consumer before endotoxin infusion, the gut became a lactate producer after the endotoxin infusion, with GLP increasing from -11.4 +/- 27.0 to 32.9 +/- 38.2 x 10(-3) mEq/min (P < 0.05). LLU increased from 48.1 +/- 26.2 to 86.6 +/- 45.2 x 10(-3) mEq/min (P < 0.05), so that LLE and HSLP did not change. In the EDTX + Tamp group, LLE became negative, and HSLP became positive only when hepatic oxygen delivery reached its critical value during cardiac tamponade. In the EDTX group, LLE remained positive and HSLP negative. In endotoxic shock, GLP is increased, but the liver can metabolize this additional load of lactate, so that the hepatosplanchnic area is not a major source of lactate unless the liver becomes profoundly hypoxic.

Protective effects of moderate hypothermia on phosphoenergetic metabolism in rat liver during gradual hypoxia studied by in vivo 31P nuclear magnetic resonance spectroscopy

BACKGROUND

Hepatic hypoxia during resuscitation and other critically ill conditions is a serious cause of acute hepatic failure. Measurement of the ATP concentration is a sensitive method to evaluate the extent of hypoxic damage in the liver. Hypothermia has been shown to attenuate organ injury in hypoxia. Our aim was to evaluate the effects of moderate hypothermia on the hepatic energy metabolism in rats during gradual hypoxia using (31)P nuclear magnetic resonance (NMR) spectroscopy.

MATERIALS AND METHODS

The rats were divided into two groups: a normothermia group (n = 8, rectal temperature at 37-37.5 degrees C) and a hypothermia group (n = 8, rectal temperature at 30-32 degrees C). The fraction of inhaled oxygen (F(I)O(2)) was reduced gradually (0.5, 0.2, 0.15, 0.125, 0.1, 1.0) and rectal temperature was regulated using a water perfusion mat under the rat body. Phosphoenergetic metabolism of the liver was evaluated from the changes in peak areas of beta-adenosine triphosphate (ATP) and inorganic phosphate (P(i)) in (31)P NMR spectra. Intracellular pH (pH(i)) was calculated from the chemical shifts between P(i) and alpha-ATP peaks.

RESULTS

In the normothermia group, beta-ATP decreased markedly and P(i) increased during hypoxia, while in the hypothermia group, both beta-ATP and P(i) changed only slightly from the initial state during hypoxia. During hypoxia, the minimal changes in beta-ATP were 18% and 80%, and the maximal changes in P(i) were 270% and 160% in the normothermia and hypothermia groups, respectively. Significant difference between the two groups was observed during hypoxia. The recoveries of beta-ATP and P(i) were more complete in the hypothermia group. The decrease in pH(i) during hypoxia was less in the hypothermia group.

CONCLUSIONS

During gradual hypoxia, beta-ATP decreased, P(i) increased, and pH(i) decreased in the rat liver, depending on the oxygen concentration. These changes were more prominent in the NT group than in the HT group. We conclude that moderate hypothermia effectively protects high energy phosphoenergetic metabolites in rat liver during gradual hypoxia as compared to normothermia.

Changes in regional blood flow and pCO2 gradients during isolated abdominal aortic blood flow reduction

OBJECTIVE

pCO(2) gradients are used for the assessment of splanchnic regional and local mucosal blood flow changes in experimental and clinical research. pCO(2) gradients may not parallel blood flow changes because of concomitant changes in metabolism, hemoglobin, temperature, and the Haldane effect.

DESIGN AND SETTING

A randomized, controlled animal experiment in a university experimental research laboratory.

INTERVENTIONS

An extracorporeal shunt with reservoir and roller pump was inserted between the proximal and the distal abdominal aorta in 16 pigs. In animals randomized to the low-flow group ( n=8) splanchnic perfusion was reduced by running the roller pump. At baseline and after 45 min of stable shunt flow superior mesenteric artery, celiac trunk, spleen artery, and portal vein blood flows and regional venous-arterial and jejunal and gastric mucosal-arterial pCO(2) gradients were measured, and the respective regional O(2) consumption rates (VO(2)) calculated.

MEASUREMENTS AND RESULTS

In the low-flow group all regional blood flows and the associated VO(2) decreased to roughly 50% of baseline values, and hemoglobin decreased from 7.3 (4.4-9.6) g/dl to 5.7 (4.1-8.9) g/dl. Decreasing regional blood flows were consistently associated with increasing regional and mucosal pCO(2) gradients.

CONCLUSIONS

During isolated reduction in abdominal aortic blood flow there is no preferential distribution to any splanchnic vascular bed and changes in regional pCO(2) gradients reflect consistently the associated blood blow changes.

Dopamine-1 receptor stimulation impairs intestinal oxygen utilization during critical hypoperfusion

Effects of a dopamine-1 (DA-1) receptor agonist on systemic and intestinal oxygen delivery (Do(2))-uptake relationships were studied in anesthetized dogs during sequential hemorrhage. Control (group 1) and experimental animals (group 2) were treated similarly except for the addition of fenoldopam (1.0 microg x kg(-1) x min(-1)) in group 2. Both groups had comparable systemic critical Do(2) (Do(2crit)), but animals in group 2 had a higher gut Do(2crit) (1.12 +/- 1.13 vs. 0.80 +/- 0.09 ml. kg(-1) x min(-1), P < 0.05). At the mucosal level, a clear biphasic delivery-uptake relationship was not observed in group 1; thus oxygen consumption by the mucosa may be supply dependent under physiological conditions. Group 2 demonstrated higher peak mucosal blood flow and lack of supply dependency at higher mucosal Do(2) levels. Fenoldopam resulted in a more conspicuous biphasic relationship at the mucosa and a rightward shift of overall splanchnic Do(2crit) despite increased splanchnic blood flow. These findings suggest that DA-1 receptor stimulation results in increased gut perfusion heterogeneity and maldistribution of perfusion, resulting in increased susceptibility to ischemia.

The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis

OBJECTIVE

To investigate the role of the splanchnic region in the hyperlactatemia of septic patients.

DESIGN

Prospective, observational study.

SETTING

Thirty-one-bed mixed medicosurgical intensive care unit.

PATIENTS

Ninety invasively monitored and mechanically ventilated patients with severe sepsis.

MEASUREMENTS AND MAIN RESULTS

Splanchnic lactate balance was measured in all patients. Splanchnic blood flow was determined by using the primed continuous indocyanine green infusion technique in 69 patients. In 71 patients, gastric mucosal Pco2 and the Pco2 gap (the difference between gastric and arterial Pco2) also were determined by using gas tonometry with an automated gas analyzer. In each patient, arterial, mixed-venous, and hepatic venous blood samples were obtained to determine hemoglobin oxygen saturations and lactate concentrations. Arterial and hepatic venous lactate concentrations were determined in triplicate and were averaged, and the arterial hepatic venous difference in lactate and lactate consumption were calculated. The splanchnic region produced lactate in only six of the 90 patients. Mean arterial pressure, cardiac index, arterial lactate, hepatic venous oxygen saturation, and catecholamine use were similar in the six patients with splanchnic lactate production and in the 84 others. The arterial hepatic venous differences in lactate and splanchnic lactate consumption were related directly to arterial lactate concentrations (y = 0.073x + 0.209, r(2) =.06, p <.05, and y = 0.06x + 0.183, r(2) =.08, p <.05, respectively) but were not related to Pco2 gap, to the gradient between mixed-venous and hepatic venous oxygen saturations, or to bilirubin concentrations.

CONCLUSIONS

Splanchnic lactate release is uncommon in septic patients, even when hyperlactatemia is severe.